The 4 Horsemen: What Actually Kills You (and the Levers That Change It)

You’re 42, sitting in a hallway chair outside an exam room, scrolling your phone while you wait for labs you didn’t think you needed. Your father had his first heart incident at 58. No warning. No chest pain the week before. Just a Tuesday, then an ambulance. You’re staring at your own reflection in a dark screen and doing math you don’t want to do: sixteen years.

That number is the whole problem. Not the heart incident itself — the sixteen years before it, silent, unmeasured, un-mentioned at a single annual physical.

The four things that actually end your life

Strip away the noise and almost every early death funnels through four doors: cardiovascular disease, cancer, type 2 diabetes and metabolic dysfunction, and neurodegenerative disease. Peter Attia calls them the Four Horsemen. Together they account for roughly 80% of deaths in people over 50 in the developed world. Not accidents. Not exotic rare disease. These four.

Here’s the twist: you’ve been taught to treat these as sudden events. A stroke. A diagnosis. A fall that reveals dementia was already advanced. But cardiovascular disease starts laying plaque in your arteries by your 20s. Cancer cells replicate quietly for 5 to 20 years before a scan catches anything. Insulin resistance — the metabolic engine behind type 2 diabetes — can run silently for a full decade before your fasting glucose ever crosses a diagnostic line. Alzheimer’s pathology shows up in brain imaging up to 20 years before the first memory lapse gets noticed at a dinner table.

You are not unlucky when one of these hits. You are almost never surprised — if you knew where to look.

You’re not broken. The system is built backwards.

The real problem isn’t your willpower, your genes, or some moral failure to eat kale. The real problem is that you were handed a healthcare system engineered to treat disease after it announces itself, not before. Your annual checkup checks a blood pressure cuff and a basic metabolic panel, then sends you home with a thumbs up — while your ApoB, your fasting insulin, your hs-CRP, your VO2 max, none of them get measured at all.

That’s not incompetence. It’s design. Reactive sick-care medicine gets paid when you’re sick, not when you stay well. The entire billing model rewards diagnosis and treatment, not the decade of prevention that would have made diagnosis unnecessary. You are not the patient in that model. You’re the eventual revenue.

Flip that, and the whole ten years changes.

The four levers, one at a time

Lever 1 — Cardiovascular disease. ApoB is the single best predictor of your cardiovascular risk, better than total cholesterol or LDL alone, because it counts the actual number of artery-clogging particles in your blood. A level under 60 mg/dL correlates with dramatically lower lifetime risk. Most standard panels never run it. Ask for it by name.

Lever 2 — Cancer. You can’t screen your way out of every cancer, but you can shift odds. Muscle mass, VO2 max, and avoiding visceral fat all correlate with lower cancer incidence and better outcomes if cancer does show up. A VO2 max in the top 25% for your age cuts all-cause mortality risk by roughly 50% compared to the bottom 25%. That’s not a small edge. That’s a different life expectancy.

Lever 3 — Metabolic disease. Fasting insulin creeps up years before glucose does. By the time a standard fasting glucose test flags “prediabetic,” you’ve often had insulin resistance brewing for 8 to 10 years. Track fasting insulin and HbA1c together, not glucose alone, and you catch the problem while it’s still cheap and reversible.

Lever 4 — Neurodegeneration. Sleep quality, cardiovascular fitness, and blood sugar control in your 40s and 50s predict dementia risk in your 70s and 80s more reliably than family history alone. You have decades to change this trajectory. Most people never get told the clock started that early.

Numbers you can act on this week

You don’t need a research budget. You need a short list: ApoB, fasting insulin, HbA1c, hs-CRP, VO2 max, and a resting heart rate trend. Six markers. Most cost less than a dinner out when bundled, and most primary care visits skip every one of them.

This is where testing platforms like InsideTracker earn their keep — you get bloodwork mapped against age- and sex-matched optimal ranges, not just “normal,” which is a much lower bar than you think. [AFFILIATE: insidetracker] gives you a starting panel built around exactly these levers, so you’re not guessing which fifteen markers actually matter out of the two hundred a lab could theoretically run.

Get your ApoB and fasting insulin baseline now, at 35 or 45, not at 60 when a cardiologist orders it for you. The difference between those two timelines is the difference between a lever and a diagnosis.

Your first move

Short version: stop waiting for symptoms. Symptoms are the disease’s last move, not its first. You get to intervene decades earlier than any wake-up call, but only if you go looking before something forces the search.

Book the panel. Read the numbers against the optimal range, not the “normal” range your lab defaults to. Then pick one lever — sleep, VO2 max, ApoB, fasting insulin — and move it for 90 days. That’s the whole first step, and it’s the one that puts you in control of a timeline your family history alone doesn’t get to write.

You are not a bystander in this story. Run the numbers, know your own risk before a hallway chair and someone else’s diagnosis forces the question, and you become the person who saw it coming — sovereign over the decade that used to belong to a system that only showed up after it was too late.